• Weight Loss Restores Gut Stretch-Induced Satiety in Obesity

  2026-06-10

  This study demonstrates that intestinal stretch acutely suppresses food intake and improves glucose tolerance, but obesity impairs this mechanosensory pathway. Both dietary and surgical weight loss restore the gut's ability to regulate satiety via mechanical stretch, pointing to non-hormonal mechanisms relevant for metabolic disease research.

• Vancomycin: Glycopeptide Antibiotic Workflows for MRSA Resea

  2026-06-10

  Vancomycin's precise inhibition of bacterial cell wall synthesis underpins its leadership in MRSA and Clostridium difficile infection research. This guide delivers actionable protocols, advanced applications, and troubleshooting insights optimized for experimental reliability.

• Enhanced mTOR Inhibitor Detection with Drug-Sensitized Yeast

  2026-06-09

  Breen et al. introduce a highly sensitive yeast-based system for identifying mTOR inhibitors, overcoming limitations of rapamycin and traditional screens. This platform increases the sensitivity for detecting TOR pathway inhibition, streamlining the discovery of new geroprotective and anti-cancer agents.

• Annexin V-FITC/PI Apoptosis Assay Kit: Mechanisms, Decisions

  2026-06-09

  Explore the scientific foundation and practical advantages of the Annexin V-FITC/PI Apoptosis Assay Kit in early apoptosis detection. This in-depth guide reveals decisive protocol insights and interprets recent hepatocyte apoptosis research for improved assay design.

• Canagliflozin: Mitochondrial Networks and Experimental Preci

  2026-06-08

  Explore Canagliflozin as a potent SGLT2 inhibitor and uncover its nuanced effects on mitochondrial remodeling in proximal tubular cells. This article provides advanced assay insights for diabetes and renal research, distinguishing itself with protocol precision and critical analysis of recent mitochondrial findings.

• AT13387 and Hsp90: Deep Mechanistic Insights for Cancer Biol

  2026-06-08

  Explore how AT13387, a potent Hsp90 inhibitor, enables advanced cancer biology research by targeting molecular chaperone networks. This article delivers unique mechanistic depth and practical assay guidance beyond current literature.

• Imidazoline Antagonists Enhance Insulin Release via K+ Chann

  2026-06-07

  This study demonstrates that imidazoline α2-adrenergic antagonists, including Tolazoline, enhance insulin secretion in vitro primarily through inhibition of ATP-sensitive potassium channels in pancreatic β cells, rather than by adrenoceptor antagonism. These findings clarify Tolazoline's mechanistic profile and guide its experimental use in islet function research.

• Tolazoline: Enabling Mechanistic Clarity in Translational Re

  2026-06-06

  Tolazoline, an imidazoline compound and robust α2-adrenergic receptor antagonist, offers translational researchers unique mechanistic leverage in dissecting neuroendocrine and airway pathways. This article presents a strategy-driven overview that integrates quantitative insights, protocol recommendations, and a forward-looking perspective on Tolazoline’s role in advancing reproducible, biologically relevant research.

• p-Cresyl Sulfate Promotes VIC Calcification via Klotho/SIRT1

  2026-06-05

  This study establishes p-Cresyl sulfate (PCS) as a direct enhancer of aortic valvular interstitial cell (VIC) calcification, acting through suppression of the klotho/SIRT1 pathway. These mechanistic insights clarify how uremic toxins contribute to calcific aortic valve disease in chronic kidney disease, highlighting potential molecular targets for intervention.

• Proteinase K: Broad-Spectrum Serine Protease for Genomic DNA

  2026-06-05

  APExBIO’s Proteinase K is a robust broad-spectrum serine protease, unlocking efficient genomic DNA isolation and contaminant removal even with challenging samples. Its superior inhibitor resistance and stability across diverse conditions make it the tool of choice for high-integrity molecular biology workflows.

• Tolazoline as an α2-Adrenergic Receptor Antagonist: Optimize

  2026-06-04

  Tolazoline’s dual action as an α2-adrenergic receptor antagonist and ATP-sensitive potassium channel blocker empowers researchers to dissect neuroendocrine and airway smooth muscle pathways with precision. This guide delivers actionable workflows, troubleshooting insights, and protocol optimizations for reproducible, high-impact results in islet function and airway studies.

• MMP-2/MMP-9-Driven BBB Disruption in Arsenic-Induced Cogniti

  2026-06-04

  The referenced study demonstrates that arsenic exposure impairs learning and memory in male mice via MMP-2 and MMP-9-mediated blood-brain barrier (BBB) disruption and neuronal apoptosis. The use of doxycycline hyclate as a matrix metalloproteinases inhibitor preserved BBB integrity and ameliorated cognitive dysfunction, offering mechanistic insight and potential translational relevance for neurovascular research.

• Octenidine (dihydrochloride): Reliable Antiseptic for Lab As

  2026-06-03

  This article examines Octenidine (dihydrochloride) (SKU C6432) as a dependable antiseptic research compound for cell viability and cytotoxicity workflows. Through scenario-based Q&A, we address practical challenges in reproducibility, compatibility, and vendor selection, supporting recommendations with published data and the APExBIO product dossier.

• Cy3 Goat Anti-Mouse IgG (H+L): Proteomics & Early Biomarker

  2026-06-03

  Explore how the Cy3 Goat Anti-Mouse IgG (H+L) Antibody empowers precise mouse IgG detection antibody workflows in serum biomarker discovery. This article uniquely bridges fluorescent secondary antibody technology with cutting-edge proteomics for early disease monitoring.

• Time-Restricted Feeding Modulates NAFLD via Hepatic Nicotina

  2026-06-02

  This study reveals how time-restricted feeding (TRF) alleviates non-alcoholic fatty liver disease (NAFLD) by reshaping hepatic nicotinamide metabolism through gut microbiota remodeling. The findings provide mechanistic insights into the interplay of metabolic pathways and suggest new directions for dietary or microbiome-based NAFLD interventions.

16505 records 1/1101 page Next 12345 下5页 Last page